Creo Medical Group PLC (AIM:CREO)
London
· Delayed Price · Currency is GBP · Price in GBX 14.88
-1.13 (-7.03%)
Jun 6, 2025, 4:35 PM GMT+1
Creo Medical Group Cash Flow Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -28.7 | -21.7 | -26.9 | -24.6 | -20.32 | Upgrade
|
| Depreciation & Amortization | 1.3 | 1.7 | 2.9 | 2.41 | 1.31 | Upgrade
|
| Other Amortization | 0.2 | - | 0.2 | 0.15 | 0.28 | Upgrade
|
| Asset Writedown & Restructuring Costs | 1.4 | - | - | - | 0.14 | Upgrade
|
| Stock-Based Compensation | 1.5 | 1.2 | 1.4 | 2.56 | 0.73 | Upgrade
|
| Other Operating Activities | 1.6 | -1.1 | 0.2 | -2.38 | -0.49 | Upgrade
|
| Change in Accounts Receivable | -1 | -1.4 | -1.6 | -3.17 | -0.39 | Upgrade
|
| Change in Inventory | 0.7 | -0.4 | -0.3 | -2.97 | 0.77 | Upgrade
|
| Change in Accounts Payable | 0.2 | -3.7 | -0.8 | 1.98 | 1.69 | Upgrade
|
| Operating Cash Flow | -22.2 | -21.6 | -24.9 | -26.01 | -16.28 | Upgrade
|
| Capital Expenditures | -0.3 | -1.2 | -3.2 | -5.98 | -0.49 | Upgrade
|
| Cash Acquisitions | - | -2.4 | -2.8 | -1.75 | -20.59 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.1 | -0.4 | -0.1 | -0.15 | -0.09 | Upgrade
|
| Investment in Securities | 15.5 | -15 | - | - | - | Upgrade
|
| Other Investing Activities | 0.2 | 0.7 | 0.1 | 0.03 | 0.2 | Upgrade
|
| Investing Cash Flow | 15.3 | -18.3 | -6 | -7.84 | -20.97 | Upgrade
|
| Long-Term Debt Issued | 6.4 | 0.2 | 2.8 | 0.14 | 2.06 | Upgrade
|
| Total Debt Issued | 6.4 | 0.2 | 2.8 | 0.14 | 2.06 | Upgrade
|
| Long-Term Debt Repaid | -1.3 | -2.1 | -2.4 | -2.36 | -0.89 | Upgrade
|
| Total Debt Repaid | -1.3 | -2.1 | -2.4 | -2.36 | -0.89 | Upgrade
|
| Net Debt Issued (Repaid) | 5.1 | -1.9 | 0.4 | -2.22 | 1.17 | Upgrade
|
| Issuance of Common Stock | 12.1 | 33.7 | - | 36.39 | 0.16 | Upgrade
|
| Other Financing Activities | -1 | -2 | - | -2.18 | - | Upgrade
|
| Financing Cash Flow | 16.2 | 29.8 | 0.4 | 31.99 | 1.33 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | 0.1 | 0.3 | -0.04 | Upgrade
|
| Net Cash Flow | 9.3 | -10.1 | -30.4 | -1.56 | -35.96 | Upgrade
|
| Free Cash Flow | -22.5 | -22.8 | -28.1 | -31.99 | -16.77 | Upgrade
|
| Free Cash Flow Margin | -562.50% | -570.00% | -103.31% | -127.13% | -177.80% | Upgrade
|
| Free Cash Flow Per Share | -0.06 | -0.07 | -0.15 | -0.20 | -0.11 | Upgrade
|
| Cash Interest Paid | 0.7 | 0.4 | 0.3 | 0.46 | 0.17 | Upgrade
|
| Cash Income Tax Paid | -2.4 | -4.5 | -4.3 | -3.4 | -2.86 | Upgrade
|
| Levered Free Cash Flow | -31.96 | -19.13 | -23.64 | -20.93 | -14.97 | Upgrade
|
| Unlevered Free Cash Flow | -31.71 | -19 | -23.51 | -20.8 | -14.93 | Upgrade
|
| Change in Net Working Capital | 17 | 3.8 | 5.52 | 1.11 | 2 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.